Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
Public ClinicalTrials.gov record NCT02510014. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Long-Term Safety and Tolerability Study of Depot Buprenorphine (RBP-6000) in Treatment-Seeking Subjects With Opioid Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A multi-center, open-label, long-term safety study in which approximately 600 subjects diagnosed with opioid use disorder will be enrolled. Following a screening period, all subjects will receive run in SUBOXONE sublingual film followed by an initial injection of open-label high dose (300 mg) RBP-6000. The RBP-6000 monthly injection dose can be adjusted to low dose (100 mg), and back to high dose, based on the medical judgment of the Investigator. Subjects will participate in the study for either 6 or 12 months.
Study identification
- NCT ID
- NCT02510014
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 775 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 27, 2015 (Actual)
- Primary completion
- Jan 31, 2017 (Actual)
- Completion
- Jan 31, 2017 (Actual)
- Last update posted
- Mar 29, 2018
2015 – 2017
United States locations
- U.S. sites
- 42
- U.S. states
- 20
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Haleyville Clinical Research | Haleyville | Alabama | 35565 | — |
| Boyett Health Services | Hamilton | Alabama | 35570 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Collaborative Neuroscience Network | Garden Grove | California | 92845 | — |
| Behavioral Research Specialists | Glendale | California | 91206 | — |
| Synergy Clinical Research Center | National City | California | 91950 | — |
| Pacific Research Partners | Oakland | California | 94612 | — |
| North County Clinical Research | Oceanside | California | 92056 | — |
| Neuropsychiatric Research Center of Orange County | Orange | California | 92868 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Amit Vijapura | Jacksonville | Florida | 32256 | — |
| Sarkis Clinical Trials | Lake City | Florida | 32025 | — |
| Meridien Research | Lakeland | Florida | 33805 | — |
| Innovative Clinical Research | Lauderhill | Florida | 33319 | — |
| Florida Clinical Research Center | Maitland | Florida | 32751 | — |
| Try Research | Maitland | Florida | 32751 | — |
| Scientific Clinical Research | North Miami | Florida | 33161 | — |
| Research Centers of America | Oakland Park | Florida | 33334 | — |
| Atlanta Institute of Medicine and Research | Alpharetta | Georgia | 30005 | — |
| Phoenix Medical Research | Prairie Village | Kansas | 66206 | — |
| Louisiana Research Associates | New Orleans | Louisiana | 70114 | — |
| Louisiana Clinical Research | Shreveport | Louisiana | 71101 | — |
| Stanley Street Treatment and Resources | Fall River | Massachusetts | 02720 | — |
| Adams Clinical Trials | Watertown | Massachusetts | 02472 | — |
| Precise Research Centers, Inc. | Flowood | Mississippi | 39232 | — |
| St Louis Clinical Trials | St Louis | Missouri | 63141 | — |
| Altea Research | Las Vegas | Nevada | 89102 | — |
| Comprehensive Clinical Research | Berlin | New Jersey | 08009 | — |
| Center for Emotional Fitness | Cherry Hill | New Jersey | 08002 | — |
| The Medical Research Network, LLC | New York | New York | 10128 | — |
| Neuro-behavioral Clinical Research | Canton | Ohio | 44718 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| Charak Clinical Research Center | Garfield Heights | Ohio | 44125 | — |
| Oklahoma Clinical Research Center | Oklahoma City | Oklahoma | 73112 | — |
| Pahl Pharmaceutical Professionals | Oklahoma City | Oklahoma | 73112 | — |
| CODA | Portland | Oregon | 97214 | — |
| Tipton Medical and Diagnostic Center aka Clinical Research Associates of Central PA | Altoona | Pennsylvania | 16602 | — |
| UPenn Treatment Research Center | Philadelphia | Pennsylvania | 19104 | — |
| Carolina Clinical Trials | Charleston | South Carolina | 29407 | — |
| Pillar Clinical Research | Dallas | Texas | 75243 | — |
| InSite Clinical Research | DeSoto | Texas | 75115 | — |
| Aspen Clinical Research, LLC | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02510014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02510014 live on ClinicalTrials.gov.